Prosjekter finansiert av KLINBEFORSK
Prosjekter finansiert etter utlysning i 2018:
| Prosjekt | Prosjektleder / Koordinerende institusjon | Sum (mill. kroner) |
|---|---|---|
| The REMNANT study – does early treatment of relapse increase survival in myeloma? | Fredrik H. Schjesvold / Oslo universitetssykehus HF | 20.0 |
| The ReSScue study; clinical and mechanistic effects of transplanting a standard cultivated gut microbiome in patients with Systemic Sclerosis | Øyvind Molberg / Oslo universitetssykehus HF | 19.0 |
| Urine based surveillance of bladder cancer patients | Guro E. Lind / Oslo universitetssykehus HF | 20.0 |
| Fecal Transplantation for Primary Clostridium Difficile Infection | Michael Bretthauer / Oslo universitetssykehus HF | 19.9 |
| Proteasome blockade to sensitize glioblastoma with unmethylated MGMT promoter to temozolomide chemotherapy | Dorota Goplen / Helse Bergen HF | 15.8 |
| Acceptance and commitment therapy with and without enhanced mindfulness training for chronic pain: A randomized controlled efficacy and mediator study | Petter Christian Borchgrevink / St.Olavs Hospital HF | 19.9 |
| The Norwegian Trial of Physical Exercise After Myocardial Infarction - NOREx | Kåre Bønaa / St.Olavs Hospital HF | 20.0 |
Prosjekter finansiert etter utlysning i 2017:
| Prosjekt | Prosjektleder / Koordinerende institusjon | Sum (mill. kroner) |
|---|---|---|
| BACK-TO-BASIC - a study of the effect of infliximab on patients with long-term lower back pain and Modic changes | John-Anker Zwart / Oslo universitetssykehus HF | 17.9 |
| Establishment of Molecular profiling for Individual clinical routine Treatment decisions in Early Breast Cancer (EMIT) | Bjørn Naume / Oslo universitetssykehus HF | 20.0 |
| BEta-Blocker Treatment after Acute Myocardial Infarction in revascularized patients with preserved left ventricular systolic function | Dan Atar / Oslo universitetssykehus HF | 15.0 |
| Improved prediction of outcome by global strain and mechanical dispersion in patients with myocardial infarction, heart failure and primary prophylactic internal defibrillator | Thor Edvardsen / Oslo universitetssykehus HF | 17.8 |
| Changing the specialist mental health care | Gerd Kvale / Helse Bergen HF | 20.0 |
| Immunotherapy for Hematological Malignancies- A Path to Cure | Henrik Hjorth-Hansen / St.Olavs Hospital HF | 5.7 |
| Innovative steroid treatment to reduce asthma development in first-time rhinovirus induced wheezing – INSTAR | Henrik Døllner / St.Olavs Hospital HF | 20.0 |
| Sphenopalatine ganglion block in chronic migraine (MIBLOCK) | Anders Mattias Linde / St.Olavs Hospital HF | 18.7 |
Prosjekter finansiert etter utlysning i 2016:
| Prosjekt | Prosjektleder/ Koordinerende institusjon | Sum (mill. kroner) |
|---|---|---|
| The Norwegian Antibiotics for Pneumonia in Children (NAPiC) study | Håvard Ove Skjerven / Oslo universitetssykehus HF | 19.3 |
| The ASAC-study: Acetylsalisylic Acid as Secondary Prevention in Colorectal Cancer | Bjørn Atle Bjørnbeth / Oslo universitetssykehus HF | 13.8 |
| The Nor-DRUM STUDY: assessing the effectiveness of tailoring infliximab treatment by therapeutic drug monitoring | Espen Andre Haavardsholm / Diakonhjemmet Sykehus AS | 12.4 |
| PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA-2) | Torbjørn Omland / Akershus universitetssykehus HF | 20.0 |
| Randomized autologous hematopoietic stem cell transplantation vs. Alemtuzumab for patients with relapsing remitting Multiple sclerosis (RAM-MS) | Lars Bø / Helse Bergen HF | 20.0 |
| A Phase 1b/2 clinical trial with Axl kinase inhibitor BGB324 in combination with Dabrafenib/Trametinib or Pembrolizumab in Metastatic Melanoma: Identification of predictive markers of response | Oddbjørn Straume / Helse Bergen HF | 17.6 |
| Tenecteplase in wake-up ischaemic stroke trial – TWIST | Ellisiv B. Mathiesen / UNN HF | 15.5 |